[Sequencing babies?].
An extension of newborn screening to genome sequencing is now feasible but raises a number of scientific, organisational and ethical issues. This is being explored in discussions and in several funded trials, in order to maximize benefits and avoid some identified risks. As some companies are already offering such a service, this is quite an urgent matter.
UMR 7268 ADÉS, Aix-Marseille, Université/EFS/CNRS, Espace éthique méditerranéen, hôpital d'adultes la Timone, 264, rue Saint-Pierre, 13385 Marseille Cedex 05, France - CoReBio PACA, case 901, parc scientifique de Luminy, 13288 Marseille Cedex 09, France.
Bertrand
B
Jordan
D004252:DNA Mutational Analysis / Q000191:economics / Q000941:ethics / Q000379:methods; D059788:Dried Blood Spot Testing / Q000191:economics / Q000379:methods / Q000592:standards; D005060:Europe; D005820:Genetic Testing / Q000191:economics / Q000941:ethics / Q000379:methods; D055106:Genome-Wide Association Study; D059014:High-Throughput Nucleotide Sequencing / Q000191:economics / Q000941:ethics / Q000379:methods; D006801:Humans; D007231:Infant, Newborn; D015997:Neonatal Screening / Q000191:economics / Q000941:ethics / Q000379:methods; D017410:Practice Guidelines as Topic; D014481:United States